Xenon Ophthalmics
Belleville, US · Founded 2019 · Delaware corporation
Founders & leadership
RG
Robert GilliganNamed on SEC filing
ZK
Zeshan KhanNamed on SEC filing
SS
Steve SusanibarNamed on SEC filing
BS
Bruce StarkNamed on SEC filing
MD
Michelle DeFossettNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 1 round · 2019
▶$2.4MraisedAug 2023 · 16 investors · BiotechnologyRule 506(b)
▶$2.4MraisedAug 2023 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert GilliganDirector
- Zeshan KhanExecutive Officer, Director
- Steve SusanibarExecutive Officer, Director
- Bruce StarkDirector
- Michelle DeFossettDirector
- Amount sold
- $2.4M
- Minimum investment
- $20K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Xenon Ophthalmics raised?
- Xenon Ophthalmics has disclosed $2.4M raised across 1 round.
- Where is Xenon Ophthalmics headquartered?
- Xenon Ophthalmics is headquartered in Belleville, US.